Anesthetic Management and Neuromonitoring in a Patient with Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency Undergoing Scoliosis Surgery: A Case Report and Review of Literature.
Anna TanakaTim CaiMichael PlattenLuis E TollincheSamuel J DeJoyPublished in: Case reports in anesthesiology (2024)
Patients with very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) are prone to hypoglycemia and clinical decompensation when metabolic demands of the body are not met. We present a pediatric patient with VLCADD who underwent a posterior spinal fusion for scoliosis requiring intraoperative neurophysiology monitoring. Challenges included minimization of perioperative metabolic stressors and careful selection of anesthetic agents since propofol-based total intravenous anesthesia (TIVA) was contraindicated due to its high fatty acid content. This case is unique due to the sequential use of inhaled anesthetics after TIVA to allow for a rapid wakeup and immediate postoperative physical exam. Additionally, intraoperative neuromonitoring in the setting of VLCADD has not been reported in the literature. With communication among anesthesia, surgery, and neuromonitoring teams before and during the operation, the patient successfully underwent a major surgery without complications. This trial is registered with NCT03808077.
Keyphrases
- fatty acid
- minimally invasive
- coronary artery bypass
- patients undergoing
- case report
- surgical site infection
- type diabetes
- clinical trial
- systematic review
- physical activity
- spinal cord
- high dose
- mental health
- cardiac surgery
- metabolic syndrome
- study protocol
- risk factors
- low dose
- tyrosine kinase
- skeletal muscle
- percutaneous coronary intervention
- phase iii
- spinal cord injury
- acute kidney injury
- coronary artery disease
- weight loss
- open label
- double blind